Skip to main content

Improving Clinical and Patient Outcomes With AI Technologies

Published

Jan 8, 2025

About this Series

TradeTalks X CES 2025

With Jill Malandrino

TradeTalks covers CES 2025.

Eric Chuang, Vice President & General Director of Biomedical Technology and Device Research Laboratories at ITRI, joins Jill Malandrino on Nasdaq TradeTalks from CES 2025 to discuss improving clinical and patient outcomes with AI technologies.

No transcript available

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/